CRVO Logo

CervoMed Inc. (CRVO) 

NASDAQ
Market Cap
$18.32M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
377 of 958
Rank in Industry
227 of 549

Largest Insider Buys in Sector

CRVO Stock Price History Chart

CRVO Stock Performance

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Insider Activity of CervoMed Inc.

Over the last 12 months, insiders at CervoMed Inc. have bought $18,160 and sold $0 worth of CervoMed Inc. stock.

On average, over the past 5 years, insiders at CervoMed Inc. have bought $18,160 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: ELDER WILLIAM ROBERT (CFO & GC) — $18,160.

The last purchase of 1,000 shares for transaction amount of $18,160 was made by ELDER WILLIAM ROBERT (CFO & GC) on 2024‑08‑27.

List of Insider Buy and Sell Transactions, CervoMed Inc.

2024-08-27PurchaseCFO & GC
1,000
0.0132%
$18.16$18,160-20.94%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.